1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow LMX 4 Topical Cream: new trials by email Literature Review of LMX 4 Topical Cream trials Research Report on LMX 4 Topical Cream
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conservative Management of Cutaneous Abscess LMX 4 Topical Cream - Cutaneous Abscess | Phase 4 | Withdrawn | Rush University Medical Center | 2025-01-01 | 2024-01-05 | |
| Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase, Rapamycin, saline - Pompe Disease | Phase 1 | Completed | University of Florida | 2 | 2017-10-17 | 2022-04-05 |
Glycogen Storage Disease Type II (1)
Rush University Medical Center (1) · University of Florida (1)
United States (2)
Brian Gulack, MD (1) · Manuela Corti, P.T., PhD. (1)